Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [<sup>177</sup>Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer.

Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [¹⁷⁷Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer.

Abouzayed, Ayman; Zedan, Wahed; Altai, Mohamed; Strand, Joanna; Örbom, Anders.

Afiliação

Abouzayed A; Department of Medicinal Chemistry, Uppsala University Uppsala, Sweden.
Zedan W; Department of Oncology, Lund University Lund, Sweden.
Altai M; Department of Oncology, Lund University Lund, Sweden.
Strand J; Department of Oncology, Lund University Lund, Sweden.
Örbom A; Department of Oncology, Lund University Lund, Sweden.

Am J Nucl Med Mol Imaging ; 13(3): 107-117, 2023.

Article em En | MEDLINE | ID: mdl-37457328